Servier Deutschland GmbH
Biotechnology, Chemical Industry, Medical Technology
-
Short facts
-
- Distributor
- Research & Development
- Year founded 1954
- 437 Employees (site)
- Turnover: 5m - <10m EUR
Products/services: Since its foundation in 1954, SERVIER has brought 40 innovative drugs from its own research to market. SERVIER Germany currently sells 9 products. The focus in Germany is on SERVIER preparations for the treatment of diseases of the cardiovascular organs (hypertension, CHD, angina pectoris, heart failure) and high blood pressure, osteoporosis and depression. SERVIER currently markets 22 innovative drugs worldwide. SERVIER's worldwide product range includes drugs for the following indications: - Hypertension - Heart failure - Angina pectoris - Venous insufficiency - Diabetes - Hyperlipidemia - Asthenia - Depression - Cerebral circulatory disorders - Infections and inflammations of the upper respiratory tract - Chronic obstructive pulmonary disease - Malignant melanoma - Osteoporosis Since its foundation in 1954, SERVIER has brought 40 innovative drugs from its own research to market. SERVIER Germany currently sells 9 products. The focus in Germany is on SERVIER preparations for the treatment of diseases of the cardiovascular organs (hypertension, CHD, angina pectoris, heart failure) and high blood pressure, osteoporosis and depression. SERVIER currently markets 22 innovative drugs worldwide. SERVIER's worldwide product range includes drugs for the following indications: - Hypertension - Heart failure - Angina pectoris - Venous insufficiency - Diabetes - Hyperlipidemia - Asthenia - Depression - Cerebral… read more
Basic data
Company
Servier Deutschland GmbH
Street
Elsenheimerstr. 53
PC / City
80687 München
County
Upper Bavaria
Phone
+49 89 5709501
Fax
+49 89 57095126
Homepage
Language skills
English, French, German
Profile/competences
Core competencies
- Research and development
- Clinical development of our pharmaceutical drugs within the German-speaking area
- Marketing and sales specifically in the indications of cardiovascular diseases (CV), diseases of the central nervous system (CNS) and osteoporosis
Key sectors / sub-sectors
- Biotechnology: Biomaterials
- Biotechnology: Therapeutic drug development
- Biotechnology: Tissue engineering and regenerative medicine
- Chemical Industry: Pharmaceutical basic products
- Medical Technology: Implants, biomaterials, tissue engineering
NACE industries
- Manufacture of basic pharmaceutical products and pharmaceutical preparations 21
- Scientific research and development 72
Certifications
not available
Sales markets - target industries
Ärzte und Apotheker in den Indikationsgruppen CV, ZNS, Osteoporose
Sales markets - target countries
not available
Cooperation offers
not available